Mast cell stabilizers appear to have the potential to control IRRs and possibly allow for the safe reintroduction of agalsidase in patients with Fabry disease who previously received enzyme ...

Postoperative ileus (POI) is known to prolong hospitalization after abdominal surgery. Although the pathophysiology of POI is not fully understood, inflammation of the intestine caused by handling ...

Please provide your email address to receive an email when new articles are posted on . The Food and Drug Administration (FDA) recently approved an expanded indication for Patanol (olopatadine HCl 0.1 ...

A standard treatment for mastocytosis is difficult to apply to individual patients based on the variable clinical course. A general consensus for using antimediator agents such as antihistamines, ...

Mast cells are involved in immune disorders so that many of the proinflammatory and tissue destructive mediators produced by these cells have been implicated in the pathogenesis of rheumatoid ...